Scientists Make Use of the Cells of a Patient to Print First 3D Heart

Scientists Make Use of the Cells of a Patient to Print First 3D Heart

The researchers from Tel Aviv University have successfully managed to print the first ever 3D heart. It makes use of cells along with biological materials from a patient. This breakthrough in the medical field was published in Advanced Science. It had managed to produce a whole heart, completely filled with cells, blood vessels, ventricles, and chambers. This has indeed turned out to be a marked improvement over attempts made earlier, which could only print simple tissues without having vessels.

The whole process of creating the heart started off with a biopsy of tissues containing fats, which are taken from patients. The cellular material collected from the tissues managed to get used as the ink meant for the printing job. This had allowed the researchers to create really complex models of tissue, which include cardiac patches and finally the whole heart. The size of the heart happens to be only close to the size of the heart of a rabbit. Still, the technology, which had made it possible, could finally result in the production of an organ, similar to the size of a human organ. As of now, hearts can only manage to contract. The researchers have the plan to get the 3D printed hearts cultured and teach them, exactly how to operate like that of the real deal. Once the procedure gets completed, they would try to transplant these into the models of animals.

Research analysts have been putting their work on 3D-printed tissues for a number of years. The ultimate goal is to create functioning organs for transplant. The scientists, who were involved in the heart project at Tel Aviv University, came up with the theory that within a span of 10 years, printers of organs might well be available at hospitals.

Research Says That Diabetes Drug Carries Benefits For Heart And Kidney

Research Says That Diabetes Drug Carries Benefits For Heart And Kidney

A new study has found that a common drug for diabetes can lower the risk of kidney failure. This particular finding has managed to raise the eyebrows of many, as diabetes is quite a major caused by kidney failure all over the world. The risk with regard to kidney failure and heart problems was on the lower side among patients with type 2 diabetes and kidney disease, who took a daily dose of canagliflozin. This was taken as part of the study that got published in a journal on Sunday.

Canagliflozin is used to reduce the risk of final stage kidney disease along with deaths due to heart or kidney problems in adults suffering from Type 2 diabetes and chronic kidney disease. The study included 4401 patients, who were aged 30 years and older, suffering from type 2 diabetes and chronic kidney disease. All those patients were assigned at 690 sites in a random manner in 34 countries to either take canagliflozin or even a placebo from March 2014 through May 2017. The researchers found out that canagliflozin reduced the risk of death from kidney problems by 34%. The risk of final stage kidney disease was lowered by 32%.

On the basis of this particular study, researchers felt that they could use canagliflozin only for benefits on a kidney. Plus, it could also carry certain heart benefits along with the use of other drugs to keep the glucose level among patients under control. It is especially applicable for those patients, who are suffering from kidney and diabetes disease. This particular trial was particularly designed to include certain individuals who had suffered from a diabetic renal problem and thus it becomes the first instance of getting the risk for kidney failures lowered and improving the outcomes of heart problems.